factual

Biotech Is Avoided by Most World-Class Investors

The vast majority of world-class investors studied say biotech is the one area they will never enter because it is too complex and requires too much specialization, which is why the founders find it attractive.

factualpending

Speaker

Rick Buhrman

Evidence Quote

“the vast majority of world-class investors we've studied, it's the only area that they say they will never go”

Source

Rick Buhrman & Paul Buser - Find Your X, Nurture Your N - [Invest Like the Best, EP.346]— Invest Like the Best
Created: 11/18/2026, 11:38:41 PM

Your notes

Loading notes...